KM Monge, SS Domene, DLD Mendoza… - Cureus, 2024 - ncbi.nlm.nih.gov
Tranexamic acid (TXA), a fibrinolytic agent, effectively inhibits plasminogen activation, thereby reducing fibrinolysis and hemorrhage. This study focused on its application in …
JM Weissler, J Banuelos, VE Molinar… - Aesthetic surgery …, 2021 - academic.oup.com
Background Tranexamic acid (TXA) has gained increasing recognition in plastic surgery as a dependable adjunct capable of minimizing blood loss, ecchymosis, and edema. To date …
S Rowe, A Liu, I Zagales, M Awan, R Santos… - Annals of Surgery …, 2021 - journals.lww.com
Methods: PubMed and Cochrane libraries were searched for relevant RCTs published between January 2011 and January 3, 2021. Cohen's Q Test for heterogeneous effects was …
Background: Pelvic bone fractures may cause extensive bleeding; however, the efficacy of tranexamic acid (TXA) usage in pelvic fracture surgery remains unclear. In this systematic …
Trans-4-(aminomethyl)-cyclohexane-1-carboxylic acid, also known as tranexamic acid (TXA), has occasionally been used to prevent postoperative recurrence of chronic subdural …
R Champaneria, P Raval, C Dorée… - Cochrane Database …, 2023 - cochranelibrary.com
Background Pelvic, hip, and long bone fractures can result in significant bleeding at the time of injury, with further blood loss if they are treated with surgical fixation. People undergoing …
JM Kazley, MA Potenza, AG Marthy, AR Arain… - JBJS …, 2020 - journals.lww.com
Team Approach: Evaluation and Management of Pelvic Ring Inju... : JBJS Reviews Team Approach: Evaluation and Management of Pelvic Ring Injuries : JBJS Reviews JBJS Journal …